Archive · 2020-04-23
AI ethics on Thursday, 23 April 2020
2 items published this day, across 1 categories.
Research (2)
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
•Baricitinib at 4 mg/day/orally was given to 12 patients with moderate COVID-19.•In baricitinib-treated patients no adverse events were recorded, after 2 weeks.•Clinical and respiratory parameters significantly improved at 2 weeks.•None of the baricitinib-treated patients required admission to ICU.•Proper control group was missing; this is required to demonstrate the efficacy. As discussed in the Journal recently1Li R. Qiao S. Zhang G Analysis of angiotensin-converting enzyme 2 (ACE2) from diffe
Drivers, barriers and social considerations for AI adoption in business and management: A tertiary study
The number of academic papers in the area of Artificial Intelligence (AI) and its applications across business and management domains has risen significantly in the last decade, and that rise has been followed by an increase in the number of systematic literature reviews. The aim of this study is to provide an overview of existing systematic reviews in this growing area of research and to synthesise their findings related to enablers, barriers and social implications of the AI adoption in busine